Assertio Historical Valuation

ASRT Stock  USD 1.01  0.07  7.45%   
Some fundamental drivers such as market cap or Assertio Therapeutics enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Assertio Therapeutics valuation indicators such as Working Capital of 0.0 or Enterprise Value of 1.6 B to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Assertio Therapeutics's future value.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Assertio Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Assertio Stock please use our How to Invest in Assertio Therapeutics guide.

About Assertio Valuation Data Analysis

Valuation is the financial process of determining what Assertio Therapeutics is worth. Assertio Therapeutics valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Assertio Therapeutics valuation ratios help investors to determine whether Assertio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Assertio with respect to the benefits of owning Assertio Therapeutics security.

Assertio Therapeutics Valuation Data Chart

Enterprise Value is likely to gain to about 1.6 B in 2024, whereas Market Cap is likely to drop slightly above 312.9 M in 2024.

Enterprise Value

Enterprise Value (or EV) is usually referred to as Assertio Therapeutics theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Assertio Therapeutics debt, but would also pocket its cash. Enterprise Value is more accurate representation of Assertio Therapeutics value than its market capitalization because it takes into account all of Assertio Therapeutics existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Assertio Stock Analysis

When running Assertio Therapeutics' price analysis, check to measure Assertio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assertio Therapeutics is operating at the current time. Most of Assertio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Assertio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assertio Therapeutics' price. Additionally, you may evaluate how the addition of Assertio Therapeutics to your portfolios can decrease your overall portfolio volatility.